IL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins. 2005

Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
Unit of Industrial Toxicology and Occupational Medicine, Faculty of Medicine, UCL, Clos Chapelle-aux-Champs, 30.54, 1200 Brussels, Belgium.

IL-9 is a Th2 cytokine that exerts pleiotropic activities, and might be involved in the regulation of lung inflammatory processes. To characterize the activity of IL-9 on lung injury, we compared the pulmonary responses to bleomycin (blm) in IL-9 transgenic (Tg5) and wild-type (FVB) mice. Following intratracheal instillation of lethal doses of blm, the mortality rate was markedly reduced in Tg5 mice compared to their wild-type counterparts (ie, 25% mortality for Tg5 versus 85% for FVB mice, 21 days after instillation of 0.05U blm/mouse). Histological and biochemical analyses showed that blm induced less lung injury and less epithelial damage in Tg5 as compared to FVB animals. This protection of Tg5 mice was accompanied by an expansion of eosinophils and B cells in the lungs. In addition, TGF-beta and prostaglandin-E2 (PGE2) levels in broncho-alveolar lavage fluid were also increased in transgenic mice. The contribution of B cells and eosinophils to the protective mechanism did not appear essential since eosinophil-deficient (IL-5 KO) and B-deficient (muMT) mice overexpressing IL-9 were also resistant to high doses of blm. We could rule out that TGF-beta was a key factor in the protective effect of IL-9 by blocking this mediator with neutralizing antibodies. Indomethacin treatment, which inhibited PGE2 production in both strains, suppressed the protection in Tg5 mice, supporting the idea that IL-9 controls blm-induced lung injury through a prostaglandin-dependent mechanism.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
October 2010, Modern rheumatology,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
November 2018, Molecular immunology,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
August 2005, American journal of physiology. Lung cellular and molecular physiology,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
January 1997, Life sciences,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
December 2014, American journal of respiratory cell and molecular biology,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
January 2016, Experimental and therapeutic medicine,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
July 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
May 2021, American journal of respiratory cell and molecular biology,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
June 2020, Journal of cellular and molecular medicine,
Mohammed Arras, and Jamila Louahed, and Jean-François Heilier, and Monique Delos, and Frank Brombacher, and Jean-Christophe Renauld, and Dominique Lison, and François Huaux
August 2013, The American journal of the medical sciences,
Copied contents to your clipboard!